33results about How to "Rapid customization" patented technology

A method for making a customized sole insert for a user is disclosed. The insert is first manufactured in various sizes, widths and arch heights so that a user may select the insert best configured for his foot. The insert is initially comprised of a bottom layer or shell; a formable layer which can be hardened into a particular shape; and a top cushion layer for contact with a wearer's foot or sock. The shell has an aperture for injecting a hardening agent to accelerate the hardening of the formable layer. After the insert is selected, the hardening agent is injected through the aperture and the wearer stands upon the top cushion layer until the formable layer has hardened. The result is a formable layer which is substantially conformed to the plantar aspect of the wearer's foot.

Embodiments of the present invention disclose a system and a method for processing a packet domain service signal, which enable a terminal that does not support an access control protocol of an Internet Protocol Multimedia Subsystem (IMS) to access the IMS and acquire the services in the IMS. An AGCF is added for shielding the differences of the users on the basis of the IMS defined in the 3GPP R5 / R6 standard, specifically, a PSTN / ISDN user accesses an AGF first, accesses the IMS through an agent function of the AGCF, and the AGCF also manages and controls the AGF. Control of the PSTN / ISDN services may be implemented in the AGCF, or in an AS added to the IMS, or the control of basic services and supplementary services may be implemented in the AGCF while the control of value-added services may be implemented in the AS.

Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract.

System and method to extend the data carrying capacity of a hybrid fiber cable (HFC) network by adding wideband RF signal capability above 1 GHz, and replacing at least some CATV active devices such as amplifiers with a new type of Coax Domain Node (CDN) device that acts to segment the CATV cable portion of the HFC network into a series of smaller domains. The CDN generally filter RF signals from 5-865 MHz, while amplifying and passing RF signals over 1 GHz. Upstream capability is enhanced because the CDN intercept 5-42 MHz upstream signals from each domain and convert to 1 GHz+ signals. Downstream capability is also enhanced because the CDN can take efficiently encoded 1 GHz+ digital data, QAM modulate it, and locally inject into each domain without crosstalk between domains. The system pushes data management and downstream from the head end to the CDN, creating more throughput.

A semantic conversion system (1900) includes a self-learning tool (1902). The self-learning tool (1902) receives input files from legacy data systems (1904). The self-learning tool (1902) includes a conversion processor (1914) that can calculate probabilities associated with candidate conversion terms so as to select an appropriate conversion term. The self-learning tool (1902) provides a fully attributed and normalized data set (1908).

An aiming device is provided including a body, an illumination device associated with the body and an optical element, where the illumination device is operable to selectively display a dot on the optical element being visible to a user. The optical element can include an upper edge and a lower edge, and the dot can display closer to the upper edge than to the lower edge, in some cases in the upper half or one third of the height of the optical element. The device can include a protective frame to which the optical element is joined, and the optical element upper edge can be unconcealed by any part of the protective frame above the upper edge, falling within an open top span of the frame. The optical element can be removable and replaceable relative to the protective frame, with a retainer plate temporarily securing the element to the frame.

The present invention provides for a gymnastics swing trainer. The device comprises two parallel side support members and two fixed rungs forming a rectangular frame. An adjustable rung may be positioned along the side support members to accommodate the size of the user. A gymnast grasps the adjustable rung while placing her feet on the lower fixed rung. The rungs should be spaced the proper distance apart to allow the gymnast to maintain the proper hollow body position required for uneven parallel bar skills. Repeated training with the device allows for the proper body position to become an automatic response or to be retained in “muscle memory” such that the gymnast can focus on the skill while maintaining proper position.

Embodiments of the invention provide shaped masses (SM) comprising one or more drugs such as proteins or polypeptides and methods for forming and delivering such SM's. One embodiment provides a SM comprising a drug e.g., a protein or polypeptide having a biological activity in the body of a mammal. The SM is formed by compression of a precursor material (PM) comprising the drug wherein an amount of biologically active drug in the SM is a minimum level to that in the PM. Drugs which may be incorporated into the SM include insulin, incretins and immunoglobulins e.g., interleukin neutralizing antibodies or TNF-α-inhibiting antibodies. Embodiments of the invention are particularly useful for the oral delivery of drugs which would be degraded within the GI tract, wherein the SM containing the drug is formed as or incorporated into a tissue penetrating member which is inserted into the intestinal wall after oral ingestion.

The present invention is a surgical drape that has several circumferential and longitudinal breakaway sections that can be easily removed to facilitate quick customization during surgery. The removable sections are fastened to the drape in a manner that reduces debris, which could cause contamination of the surgery field, as well as limit the potential injury to patients caused by the current use of scissors to customize drapes while in surgery.